#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma
Click to read this study in The Lancet Oncology.
Tag: cutaneous melanoma
#VisualAbstract: Adjuvant pembrolizumab improves distant metastasis-free survival in stage IIB-C melanoma
Click to read this study in The Lancet Oncology.
Nivolumab plus ipilimumab improves recurrence-free survival in patients with resected advanced melanoma
1. 4-year recurrence-free survival was significantly higher with nivolumab plus ipilimumab compared to placebo. 2. Overall survival was significantly higher ...
#VisualAbstract: Pembrolizumab reduces disease recurrence in completely resected stage IIB/IIC melanoma
Click to read this study in The Lancet Oncology.
#VisualAbstract: Acral lentiginous melanoma may be associated with higher rates of sentinel lymph node positivity compared to other melanoma subtypes
Click to read this study in JAMA Dermatology.
#VisualAbstract: Hereditary retinoblastoma survivors are at an increased risk for melanoma and non-melanoma skin cancers
Click to read this study in the Journal of Investigative Dermatology.
#VisualAbstract: High-dose glucocorticoids may be detrimental for the management of patients with advanced melanoma expieriencing immune-related adverse events
Click to read the study in Clinical Cancer Research.
#VisualAbstract: Melanoma survival outcomes have improved between 2003 and 2019 amidst increasing incidence rates
Click to read the study in the European Journal of Cancer.
#VisualAbstract: Topical calcineurin inhibitor and phototherapy use do not increase lymphoma and skin cancer risk in patients with vitiligo
Click to read the study in the Journal of the American Academy of Dermatology.